A novel preventative HIV vaccination strategy based on innate, allogenic and mucosal immunity

Lehner, Tom (Primary Investigator)
Bergmeier, Lesley (Co-Investigator)
Vaughan, Robert (Co-Investigator)

Project: Research

Status	Finished
Effective start/end date	1/04/2006 → 31/03/2011

Collaborative partners

King's College London (lead)
Dako Denmark A/S
LIONEX Diagnostics & Therapeutics GmbH
National Center for AIDS/STD Control and Prevention (NCAIDS)
Sanquin Blood Supply Foundation
Karolinska Institute
AMC Medical Research B.V.
NIAID National Institute of Allergy and Infectious Diseases, National Institutes of Health

Funding

Bill & Melinda Gates Foundation: £2,888,470.00
Bill & Melinda Gates Foundation: £107,756.00